Self-complementary AAV-mediated Gene Therapy Restores Cone Function and Prevents Cone Degeneration in Two Models of Rpe65 Deficiency

Overview

Journal Gene Ther

Date 2010 Mar 19

PMID 20237510

Citations 46

Authors

J Pang

S E Boye

B Lei

S L Boye

D Everhart

R Ryals

Y Umino

B Rohrer

J Alexander

J Li

X Dai

Q Li

B Chang

R Barlow

W W Hauswirth

Affiliations

Soon will be listed here.

Abstract

To test whether fast-acting, self-complimentary (sc), adeno-associated virus-mediated RPE65 expression prevents cone degeneration and/or restores cone function, we studied two mouse lines: the Rpe65-deficient rd12 mouse and the Rpe65-deficient, rhodopsin null ('that is, cone function-only') Rpe65(-/-)::Rho(-/-) mouse. scAAV5 expressing RPE65 was injected subretinally into one eye of rd12 and Rpe65(-/-)::Rho(-/-) mice at postnatal day 14 (P14). Contralateral rd12 eyes were injected later, at P35. Rd12 behavioral testing revealed that rod vision loss was prevented with either P14 or P35 treatment, whereas cone vision was only detected after P14 treatment. Consistent with this observation, P35 treatment only restored rod electroretinogram (ERG) signals, a result likely due to reduced cone densities at this time point. For Rpe65(-/-)::Rho(-/-) mice in which there is no confounding rod contribution to the ERG signal, cone cells and cone-mediated ERGs were also maintained with treatment at P14. This work establishes that a self-complimentary AAV5 vector can restore substantial visual function in two genetically distinct models of Rpe65 deficiency within 4 days of treatment. In addition, this therapy prevents cone degeneration but only if administered before extensive cone degeneration, thus supporting continuation of current Leber's congenital amaurosis-2 clinical trials with an added emphasis on cone subtype analysis and early intervention.

Citing Articles

Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration.

She K, Liu Y, Zhao Q, Jin X, Yang Y, Su J Signal Transduct Target Ther. 2023; 8(1):57.

PMID: 36740702 PMC: 9899767. DOI: 10.1038/s41392-022-01234-1.

Retinal Structure and Function in a Knock-in Mouse Model for the p.Arg523∗ Human Nonsense Pathogenic Variant.

Matsevich C, Gopalakrishnan P, Obolensky A, Banin E, Sharon D, Beryozkin A Ophthalmol Sci. 2022; 3(1):100229.

PMID: 36420180 PMC: 9676433. DOI: 10.1016/j.xops.2022.100229.

Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.

Tawfik M, Chen F, Goldberg J, Sabel B Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(12):1477-1507.

PMID: 36107200 PMC: 9630211. DOI: 10.1007/s00210-022-02287-3.

Clinical applications of retinal gene therapies.

Fu X, Huu V, Duan Y, Kermany D, Valentim C, Zhang R Precis Clin Med. 2022; 1(1):5-20.

PMID: 35694125 PMC: 8982485. DOI: 10.1093/pcmedi/pby004.

In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration.

Choi E, Suh S, Foik A, Leinonen H, Newby G, Gao X Nat Commun. 2022; 13(1):1830.

PMID: 35383196 PMC: 8983734. DOI: 10.1038/s41467-022-29490-3.

References

Hauswirth W, Lewin A, Zolotukhin S, Muzyczka N . Production and purification of recombinant adeno-associated virus. Methods Enzymol. 2000; 316:743-61. DOI: 10.1016/s0076-6879(00)16760-6. View

Pang J, Lauramore A, Deng W, Li Q, Doyle T, Chiodo V . Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vision Res. 2007; 48(3):377-85. DOI: 10.1016/j.visres.2007.08.009. View

Timmers A, Zhang H, Squitieri A, Gonzalez-Pola C . Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol Vis. 2001; 7:131-7. View

Seeliger M, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E . New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet. 2001; 29(1):70-4. DOI: 10.1038/ng712. View

McCarty D, Fu H, Monahan P, Toulson C, Naik P, Samulski R . Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 2003; 10(26):2112-8. DOI: 10.1038/sj.gt.3302134. View

Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz A, Clerin E . Identification and characterization of rod-derived cone viability factor. Nat Genet. 2004; 36(7):755-9. DOI: 10.1038/ng1386. View

Hewitt A, Lindsey J, Carbott D, Adler R . Photoreceptor survival-promoting activity in interphotoreceptor matrix preparations: characterization and partial purification. Exp Eye Res. 1990; 50(1):79-88. DOI: 10.1016/0014-4835(90)90013-k. View

Bird A . Investigation of disease mechanisms in retinitis pigmentosa. Ophthalmic Paediatr Genet. 1992; 13(2):57-66. DOI: 10.3109/13816819209087605. View

Humphries M, Rancourt D, Farrar G, Kenna P, Hazel M, Bush R . Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet. 1997; 15(2):216-9. DOI: 10.1038/ng0297-216. View

10.

Marlhens F, Bareil C, Griffoin J, Zrenner E, AMALRIC P, Eliaou C . Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet. 1997; 17(2):139-41. DOI: 10.1038/ng1097-139. View

11.

Petters R, Alexander C, Wells K, Collins E, SOMMER J, Blanton M . Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol. 1997; 15(10):965-70. DOI: 10.1038/nbt1097-965. View

12.

Redmond T, Yu S, Lee E, Bok D, HAMASAKI D, Chen N . Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998; 20(4):344-51. DOI: 10.1038/3813. View

13.

Ostrer H, Pullarkat R, Kazmi M . Glycosylation and palmitoylation are not required for the formation of the X-linked cone opsin visual pigments. Mol Vis. 1998; 4:28. View

14.

Lem J, Krasnoperova N, Calvert P, Kosaras B, Cameron D, Nicolo M . Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc Natl Acad Sci U S A. 1999; 96(2):736-41. PMC: 15206. DOI: 10.1073/pnas.96.2.736. View

15.

Pang J, Chang B, Hawes N, Hurd R, Davisson M, Li J . Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Mol Vis. 2005; 11:152-62. View

16.

Znoiko S, Rohrer B, Lu K, Lohr H, Crouch R, Ma J . Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65-/- mouse at early ages. Invest Ophthalmol Vis Sci. 2005; 46(4):1473-9. DOI: 10.1167/iovs.04-0653. View

17.

Mata N, Ruiz A, Radu R, Bui T, Travis G . Chicken retinas contain a retinoid isomerase activity that catalyzes the direct conversion of all-trans-retinol to 11-cis-retinol. Biochemistry. 2005; 44(35):11715-21. PMC: 2851629. DOI: 10.1021/bi050942m. View

18.

Rohrer B, Lohr H, Humphries P, Redmond T, Seeliger M, Crouch R . Cone opsin mislocalization in Rpe65-/- mice: a defect that can be corrected by 11-cis retinal. Invest Ophthalmol Vis Sci. 2005; 46(10):3876-82. DOI: 10.1167/iovs.05-0533. View

19.

Maguire A, Simonelli F, Pierce E, Pugh Jr E, Mingozzi F, Bennicelli J . Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008; 358(21):2240-8. PMC: 2829748. DOI: 10.1056/NEJMoa0802315. View

20.

Bainbridge J, Smith A, Barker S, Robbie S, Henderson R, Balaggan K . Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008; 358(21):2231-9. DOI: 10.1056/NEJMoa0802268. View